PROCEPT BioRobotics Corpo...

NASDAQ: PRCT · Real-Time Price · USD
41.59
1.47 (3.66%)
At close: Aug 15, 2025, 3:59 PM
42.00
1.00%
After-hours: Aug 15, 2025, 07:57 PM EDT

PROCEPT BioRobotics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
79.18M 69.16M 68.24M 58.37M 53.35M 44.54M 43.58M 35.1M 33.1M 24.4M 23.78M 20.35M 16.69M 14.2M 10.14M 8.67M 8.48M 7.19M
Cost of Revenue
27.44M 25M 24.56M 21.46M 23.14M 19.5M 23.64M 16.23M 14.68M 11.91M 13.1M 10.12M 8.21M 6.5M 5.62M 4.43M 4.89M 3.67M
Gross Profit
51.75M 44.16M 43.67M 36.91M 30.21M 25.03M 19.94M 18.87M 18.43M 12.49M 10.68M 10.23M 8.49M 7.69M 4.52M 4.24M 3.58M 3.53M
Operating Income
-22.19M -27.44M -19.71M -22.43M -26.83M -27.65M -29.56M -25.61M -25.63M -28.38M -25.04M -22.11M -17.88M -15.7M -16.83M -12.8M -13.19M -11.34M
Interest Income
-3.58M 3.58M 3.33M 2.59M 2.23M 2.74M 3.46M 2.01M 1.3M 779K 1.48M 947K 132K 36K 27K 163K 48K 14K
Pretax Income
-19.58M -24.74M -18.86M -20.97M -25.63M -25.96M -27.5M -24.62M -25.29M -28.48M -28.17M -22.61M -19.18M -17.18M -18.35M -14.1M -14.58M -12.82M
Net Income
-19.58M -24.74M -18.86M -20.97M -25.63M -25.96M -27.5M -24.62M -25.29M -27.7M -31.3M -23.12M -20.49M -18.67M -18.35M -14.1M -14.58M -12.82M
Selling & General & Admin
56.3M 55.2M 48.32M 42.69M 40.81M 39.6M 36.32M 32.88M 32.44M 30.13M 26.03M 24.75M 19.66M 18.39M 16.27M 12.12M 12.3M 10.35M
Research & Development
17.63M 16.4M 15.07M 16.65M 16.23M 13.08M 13.18M 11.6M 11.61M 10.74M 9.68M 7.58M 6.71M 5.01M 5.08M 4.92M 4.48M 4.52M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -59K -67K -52K -27K -9K
Operating Expenses
73.93M 71.6M 63.38M 59.34M 57.04M 52.68M 49.49M 44.48M 44.05M 40.87M 35.72M 32.34M 26.36M 23.4M 21.35M 17.04M 16.77M 14.87M
Interest Expense
-2.65M 877K 969K 1.14M 1.03M 1.04M 1.13M 1.02M 965K 886K 866K 1.46M 1.44M 1.42M 1.44M 1.47M 1.44M 1.46M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
101.37M 96.6M 87.95M 80.8M 80.18M 72.19M 73.14M 60.71M 58.73M 52.78M 48.82M 42.45M 34.57M 29.9M 26.97M 21.46M 21.67M 18.54M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -779K 3.13M 508K 1.31M 1.48M n/a n/a n/a n/a
Shares Outstanding (Basic)
55.45M 54.92M 53.84M 52.01M 51.62M 51.01M 50.59M 48.31M 45.16M 45.07M 44.77M 44.64M 44.32M 43.85M 43.54M 42.38M 41.21M 35.14M
Shares Outstanding (Diluted)
55.45M 54.92M 53.84M 52.01M 51.62M 51.01M 50.59M 48.31M 45.16M 45.07M 44.77M 44.64M 44.32M 43.85M 43.54M 42.38M 41.21M 35.14M
EPS (Basic)
-0.35 -0.45 -0.35 -0.4 -0.5 -0.51 -0.54 -0.51 -0.56 -0.61 -0.7 -0.52 -0.46 -0.43 -0.42 -0.33 -0.35 -0.36
EPS (Diluted)
0.45 -0.45 -0.35 -0.4 -0.5 -0.51 -0.54 -0.51 -0.56 -0.61 -0.7 -0.52 -0.46 -0.43 -0.42 -0.33 -0.35 -0.36
EBITDA
-23.66M -22.39M -16.43M -18.51M -23.33M -23.73M -25.06M -22.55M -23.86M -26.31M -25.81M -19.62M -17.02M -15.1M -16.24M -11.93M -12.27M -10.52M
EBIT
-22.19M -23.86M -17.89M -19.83M -24.6M -24.91M -26.38M -23.6M -24.32M -27.6M -27.31M -21.16M -17.74M -15.7M -16.91M -12.63M -13.14M -11.36M
Depreciation & Amortization
-1.48M 1.48M 1.45M 1.33M 1.27M 1.18M 1.32M 1.05M 462K 1.29M 1.5M 1.54M 721K 661K 667K 705K 871K 836K